ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

In addition to determining the hormone receptor and HER2 protein status, healthcare teams use the TNM system to identify the stages. This system notes: Your oncologist will use scoring of these ...

Patients and Methods: A total of 320 patients with AOC were centrally screened for HER2 status (243 patients in fi rst line, 77 in relapse). All positive (IHC 3+) and doubtful (IHC 2+) cases were ...

Your doctor will order one or more tests to understand your HER2 status, starting with an Immunohistochemistry (IHC) to measure the level of HER2 proteins on the surface of cancer cells.

Now, those patients with low HER2 status might be eligible for targeted treatment and a significant potential improvement in outcome, as they will be considered for the specifically engineered ...

Not significant different from CISH HER2 signals in a two tailed, paired t-test (N = 348, P = 0.245) d) Not significant different from CISH HER2 signals in a two-tailed, paired t-test (N = 350 ...

The Company is currently organizing additional data in relation to the recently-completed treatment phase of its Phase 2b trial of OST-HER2 in the prevention of recurrence of lung metastatic ...